James W. Welsh - Concepedia

Author

James W. Welsh

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

J Welsh, J. Welsh, J.W. Welsh, JAMES WELSH, James W Welsh, James W. Welsh, James Welsh, James William Welsh, Welsh, James, Welsh, James W.

541

Publications

17K

Citations

H-Index

114

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Shandong First Medical University Shandong Tumor Hospital Allegheny General Hospital Koç University

About

James W. Welsh is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	76	7.2K
2	Health Sciences	29	41	2.7K
3	Engineering	1	1	43
4	Management	1	1	13
5	Natural Sciences	1	1	270

James W. Welsh

137

Publications

14.2K

Citations

H-Index

Page 1

	Year	Citations
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study Daniel R. Gomez, Chad Tang, Jianjun Zhang, Journal of Clinical Oncology	2019	1.2K
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression Limo Chen, Don L. Gibbons, Sangeeta Goswami, Nature Communications Intratumoral ImmunosuppressionMicrorna-200/zeb1 Axis ControlMedicineImmunologyTumor Immunity	2014	970
PDL1 Regulation by p53 via miR-34 María Angélica Cortez, Cristina Ivan, David R. Valdecanas, JNCI Journal of the National Cancer Institute	2015	657
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials Willemijn S.M.E. Theelen, Dawei Chen, Vivek Verma, The Lancet Respiratory Medicine MedicineRandomised TrialsImmune Checkpoint InhibitorBronchial NeoplasmCancer Treatment	2020	540
<i>WISP</i> genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors Diane Pennica, Todd A. Swanson, James W. Welsh, Proceedings of the National Academy of Sciences PathologyWisp InductionCancer BiologyTumor BiologySignaling Pathway	1998	510
Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer James W. Welsh, Ritsuko Komaki, Arya Amini, Journal of Clinical Oncology	2013	392
Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes Chad Tang, Zhongxing Liao, Daniel R. Gomez, International Journal of Radiation OncologyBiologyPhysics Lymphopenia AssociationMedicineLung V5PathologyBronchial Neoplasm	2014	360
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells Chad Tang, James W. Welsh, Patricia M. de Groot, Clinical Cancer Research	2016	309
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery Joe Y. Chang, Reza J. Mehran, Lei Feng, The Lancet Oncology Surgical OncologyRadiation TherapyMedicineBronchial NeoplasmThoracic Surgery	2021	304
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial James W. Welsh, Hari Menon, Dawei Chen, Journal for ImmunoTherapy of Cancer	2020	273

Page 1